Data / Drug companies / Dextromethorphan hydrobromide, guaifenesin
Dextromethorphan hydrobromide, guaifenesin: 49 companies and 86 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Dextromethorphan hydrobromide, guaifenesin is listed in the FDA National Drug Code Directory by 49 companies, with 86 products in commercial distribution. 20 of the products (23.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; tablet, extended release; liquid, and the newest product started marketing on July 15, 2026.
The request: Get every company that lists dextromethorphan hydrobromide, guaifenesin in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 49
- Products
- 86
- Generic (ANDA) products
- 20 (23.3%)
- Application numbers
- 6
- Routes
- Oral, Topical
- Brand names
- Adult Tussin DM, Good Sense Tussin DM, Mucus Relief DM, Good Sense Mucus DM, Giltuss HBP Cough and Chest Congestion, Giltuss Childrens Cough and Chest Congestion, Mucus Relief DM, Rugby Mucus Relief DM Er
- openFDA record search
- api.fda.gov
Companies that list dextromethorphan hydrobromide, guaifenesin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| CVS Woonsocket Prescription Center, Incorporated | 6 | solution; tablet, extended release | Over the counter monograph drugs | March 3, 2026 |
| Rugby Laboratories | 4 | tablet, extended release; liquid | Over the counter monograph drugs | April 16, 2025 |
| Walgreen Company | 4 | tablet, extended release; solution | Generic drugs (ANDA) | February 5, 2024 |
| A-S Medication Solutions | 3 | solution; tablet, extended release | Over the counter monograph drugs | April 16, 2025 |
| Amerisource Bergen | 3 | solution; tablet, extended release | Over the counter monograph drugs | September 12, 2025 |
| Dextrum Laboratories, Inc | 3 | solution | Over the counter monograph drugs | November 13, 2018 |
| Dolgencorp, Inc. (dollar General & Rexall) | 3 | solution; tablet, extended release | Over the counter monograph drugs | July 1, 2026 |
| Gil Pharmaceutical Corp | 3 | solution | Over the counter monograph drugs | November 13, 2018 |
| Haleon US Holdings LLC | 3 | tablet, extended release; liquid | Over the counter monograph drugs | June 14, 2019 |
| Preferred Pharmaceuticals Inc. | 3 | solution | Over the counter monograph drugs | January 23, 2023 |
| Reckitt Benckiser LLC | 3 | liquid; tablet, coated | Over the counter monograph drugs | July 1, 2025 |
| Rite Aid Corporation | 3 | solution; tablet, extended release | Over the counter monograph drugs | March 15, 2023 |
| Cardinal Health 110, LLC. DBA Leader | 2 | tablet, extended release; solution | Generic drugs (ANDA) | March 8, 2025 |
| Discount Drug Mart | 2 | liquid | Over the counter monograph drugs | November 19, 2014 |
| Gadal Laboratories, Inc | 2 | liquid; syrup | Over the counter monograph drugs | April 14, 2025 |
| L. Perrigo Company | 2 | tablet, extended release; solution | Generic drugs (ANDA) | April 16, 2022 |
| Meijer, Inc. | 2 | solution | Over the counter monograph drugs | July 1, 2026 |
| United Natural Foods, Inc. DBA Unfi | 2 | tablet, extended release; solution | Generic drugs (ANDA) | June 8, 2022 |
| Vivunt Pharma LLC | 2 | liquid | Over the counter monograph drugs | May 14, 2024 |
| Walmart Inc. | 2 | solution; tablet, extended release | Over the counter monograph drugs | June 17, 2022 |
| Actipharma, LLC | 1 | liquid | Over the counter monograph drugs | February 12, 2026 |
| Advanced Generic Corporation | 1 | liquid | Over the counter monograph drugs | July 1, 2012 |
| Amazon.com Services LLC | 1 | solution | Over the counter monograph drugs | July 22, 2022 |
| AptaPharma Inc. | 1 | liquid | Over the counter monograph drugs | January 30, 2024 |
| Bayer HealthCare LLC. | 1 | tablet, effervescent | Over the counter monograph drugs | April 5, 2022 |
| CVS Pharmacy | 1 | solution | Over the counter monograph drugs | July 12, 2022 |
| Demoulas Super Markets, Inc | 1 | liquid | Over the counter monograph drugs | October 1, 2012 |
| H E B | 1 | liquid | Over the counter monograph drugs | September 14, 2012 |
| H E B | 1 | solution | Over the counter monograph drugs | April 22, 2022 |
| HyVee Inc | 1 | tablet, extended release | Generic drugs (ANDA) | February 25, 2026 |
| Kramer Novis | 1 | syrup | Over the counter monograph drugs | October 2, 2013 |
| Magno-Humphries, Inc. | 1 | tablet | Over the counter monograph drugs | April 4, 2017 |
| Major Pharmaceuticals | 1 | solution | Over the counter monograph drugs | January 7, 2022 |
| Meijer Distribution Inc | 1 | tablet, extended release | Generic drugs (ANDA) | June 2, 2020 |
| Menper Distributors, Inc. | 1 | liquid | Over the counter monograph drugs | April 1, 2019 |
| Navajo Manufacturing Company Inc. | 1 | tablet, extended release | New drug applications (NDA) | September 23, 2016 |
| Publix Super Markets Inc | 1 | solution | Over the counter monograph drugs | July 21, 2022 |
| Retail Business Services, LLC | 1 | solution | Over the counter monograph drugs | July 13, 2022 |
| Safeway | 1 | solution | Over the counter monograph drugs | July 15, 2026 |
| Salado Sales, Inc. | 1 | liquid | Over the counter monograph drugs | January 1, 2012 |
| Sato Pharmaceutical Co., Ltd. | 1 | syrup | Over the counter monograph drugs | January 3, 2001 |
| Southern Sales & Service, Inc. | 1 | liquid | Over the counter monograph drugs | February 1, 2023 |
| Sportpharm LLC | 1 | tablet, extended release | Generic drugs (ANDA) | July 10, 2019 |
| Strategic Sourcing Services LLC | 1 | solution | Over the counter monograph drugs | October 25, 2023 |
| Strive Pharmaceuticals Inc. | 1 | tablet | Over the counter monograph drugs | June 1, 2026 |
| Target Corporation | 1 | tablet, extended release | Generic drugs (ANDA) | July 15, 2019 |
| Topco Associates LLC | 1 | tablet, extended release | Generic drugs (ANDA) | July 10, 2019 |
| Topco Associates LLC | 1 | solution | Over the counter monograph drugs | May 11, 2022 |
| Valu Merchandisers Company | 1 | liquid | Over the counter monograph drugs | September 30, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 39 | 45.3% |
| Tablet, extended release | 21 | 24.4% |
| Liquid | 17 | 19.8% |
| Syrup | 3 | 3.5% |
| Tablet | 2 | 2.3% |
| Capsule, liquid filled | 2 | 2.3% |
| Tablet, coated | 1 | 1.2% |
| Tablet, effervescent | 1 | 1.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 65 | 75.6% |
| Generic drugs (ANDA) | 20 | 23.3% |
| New drug applications (NDA) | 1 | 1.2% |
Pharmacologic classes
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.